共 50 条
- [41] Effects of CYP3A4 inhibition/induction, and OATP inhibition on the pharmacokinetics of atogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trialsHEADACHE, 2022, 62 : 107 - 107Boinpally, R.Chen, W.McGeeney, D.Trugman, J. M.
- [42] Bioequivalence of Generic and Branded Subcutaneous Enoxaparin: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Chinese Male SubjectsCLINICAL THERAPEUTICS, 2009, 31 (07) : 1559 - 1567Feng, LiminShen-Tu, JianzhongLiu, JianChen, JunchunWu, LihuaHuang, Mingzhu
- [43] Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I StudyDRUGS IN R&D, 2024, 24 (04) : 531 - 538Jia, CaiyunZhao, NaSong, HaojingHu, YitingXu, YufangGuo, CaihuiBai, WanjunDong, Zhanjun
- [44] A randomized, open-label, two-period crossover study to evaluate the bioequivalence and food effect between two formulations of regorafenib in healthy adult participantsFRONTIERS IN PHARMACOLOGY, 2025, 16Li, YanQi, LuYang, CaixiaZhao, NaWang, Xinghe
- [45] Bioavailability of two single-dose oral formulations of omeprazole 20 mg:: An open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteersCLINICAL THERAPEUTICS, 2008, 30 (04) : 693 - 699Poo, Jorge LuisGalan, Juan FranciscoRosete, Alejandrade Lago, AlbertoOliva, IvanGonzalez-de la Parra, MarioJimenez, PatriciaBurke-Fraga, VictoriaNamur, Salvador
- [46] Relative Bioavailability and Tolerability of Two Formulations of Bicalutamide 50-mg Tablets: A Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Male SubjectsCLINICAL THERAPEUTICS, 2010, 32 (14) : 2496 - 2501Lee, SeungHwanYoon, Seo HyunCho, Joo-YounShin, Sang-GooJang, In-JinYu, Kyung-Sang
- [47] Bioequivalence and Pharmacokinetic Comparison of a Single 200-mg Dose of Meclofenoxate Hydrochloride Capsule and Tablet Formulations in Healthy Chinese Adult Male Volunteers: A Randomized Sequence, Open-Label, Two-Period Crossover StudyCLINICAL THERAPEUTICS, 2008, 30 (09) : 1651 - 1657Zou, Jian-JunJi, Hong-JianWu, Ding-WeiYao, JingHu, QinXiao, Da-WeiWang, Guang-Ji
- [48] The Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Mirodenafil in Healthy Korean Male Volunteers: An Open-Label, One-Sequence, Three-Period, Three-Treatment Crossover StudyCLINICAL THERAPEUTICS, 2009, 31 (12) : 3009 - 3020Shin, Kwang-HeeKim, Bo-HyungKim, Tae-EunKim, Jae WooYi, SoJeongYoon, Seo-HyunCho, Joo-YounShin, Sang-GooJang, In-JinYu, Kyung-Sang
- [49] Pharmacokinetic and Bioequivalence Comparison Between Orally Disintegrating and Conventional Tablet Formulations of Flurbiprofen: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Chinese Male VolunteersCLINICAL THERAPEUTICS, 2009, 31 (08) : 1787 - 1795Liu, Yan-MeiLiu, Gang-YiLiu, YunLi, Shui-JunJia, Jing-YingZhang, Meng-QiLu, ChuanZhang, Yong-MeiLi, Xue-NingYu, Chen
- [50] Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trialFRONTIERS IN PHARMACOLOGY, 2025, 15Qiu, BoSong, HaojingSun, XueDing, CongyangDu, RunxuanBai, WanjunDong, Zhanjun